Clinical trial of methyl clofenapate (a derivative of clofibrate) in patients with essential hyperlipidaemias--with special reference to type II (primary) hyperlipidaemia.
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D001797:Blood Protein Electrophoresis; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D003402:Creatine Kinase / Q000032:analysis; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000235:genetics*; D008074:Lipoproteins / Q000097:blood; D008297:Male; D009203:Myocardial Infarction; D014280:Triglycerides / Q000097:blood; D014461:Ultracentrifugation
D000924:Anticholesteremic Agents; D008074:Lipoproteins; D014280:Triglycerides; D002784:Cholesterol; D001219:Aspartate Aminotransferases; D003402:Creatine Kinase; D002994:Clofibrate